Galina S Zamay Selected Research

Proteins (Proteins, Gene)

6/2023	Development of DNA aptamers for visualization of glial brain tumors and detection of circulating tumor cells.
1/2020	Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer.
3/2019	Development of DNA Aptamers to Native EpCAM for Isolation of Lung Circulating Tumor Cells from Human Blood.
11/2017	Current and Prospective Protein Biomarkers of Lung Cancer.
3/2017	DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma.
1/2017	In Vivo Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field.
10/2016	Electrochemical aptasensor for lung cancer-related protein detection in crude blood plasma samples.
9/2015	Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Galina S Zamay Research Topics

Disease

16	Neoplasms (Cancer) 06/2023 - 04/2014
8	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2015
4	Circulating Neoplastic Cells 06/2023 - 09/2015
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2017
2	Neoplasm Metastasis (Metastasis) 11/2017 - 09/2015
2	Adenocarcinoma of Lung 03/2017 - 09/2015
1	Meningioma (Meningiomas) 06/2023
1	Central Nervous System Neoplasms 06/2023
1	Brain Neoplasms (Brain Tumor) 06/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Epilepsy (Aura) 03/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2019
1	Ascites 04/2014
1	Adenocarcinoma 04/2014

Drug/Important Bio-Agent (IBA)

12	Nucleotide AptamersIBA 06/2023 - 04/2014
8	Proteins (Proteins, Gene)FDA Link 06/2023 - 09/2015
3	AntibodiesIBA 03/2019 - 03/2017
3	GoldIBA 12/2017 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 11/2017 - 09/2015
2	Nucleic AcidsIBA 12/2022 - 03/2020
2	OligonucleotidesIBA 01/2020 - 11/2017
2	Fibronectins (Fibronectin)IBA 01/2020 - 01/2017
2	arabinogalactanIBA 01/2020 - 04/2014
2	VimentinIBA 09/2015 - 04/2014
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2022
1	DNA PrimersIBA 12/2021
1	Tumor Biomarkers (Tumor Markers)IBA 11/2021
1	A-Form DNA (A-DNA)IBA 09/2021
1	LigandsIBA 05/2021
1	Syntex adjuvant formulationIBA 05/2021
1	Asialoglycoprotein ReceptorIBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 03/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Monoclonal AntibodiesIBA 03/2017
1	IntegrinsIBA 01/2017
1	Contrast MediaIBA 01/2017
1	hexacyanoferrate II (ferrocyanide)IBA 10/2016
1	hexacyanoferrate III (ferricyanide)IBA 10/2016
1	SolutionsIBA 10/2016
1	StreptavidinIBA 10/2016
1	Histones (Histone)IBA 09/2015
1	Annexin A2 (Annexin II)IBA 09/2015
1	Annexin A5IBA 09/2015
1	DefensinsIBA 09/2015
1	ClusterinIBA 09/2015

Therapy/Procedure

10	Therapeutics 12/2021 - 04/2014
2	Lasers (Laser) 01/2023 - 12/2017
2	Precision Medicine 05/2021 - 01/2020
1	Injections 12/2017
1	Photothermal Therapy 12/2017
1	Microelectrodes 10/2016